Hemophilia Clinical Trials

• Severe Hemophilia A Study
  ClinicalTrials.gov Identifier: NCT00037544 - Active, not recruiting
  Hemophilia A
  
• Hemophilia A Study
  ClinicalTrials.gov Identifier: NCT00038935 - Active, not recruiting
  Hemophilia A
  
• Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) with Hemophilia B
  ClinicalTrials.gov Identifier: NCT00093171 - Active, not recruiting
  Hemophilia B
  
• The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
  ClinicalTrials.gov Identifier: NCT00212459 - Active, not recruiting
  Hemophilia A; Hemophilia B
  
• Study Evaluating Allergic Reactions to Benefix in Hemophilia B Patients
  ClinicalTrials.gov Identifier: NCT00244114 - Recruiting
  Hemophilia B
  
• Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
  ClinicalTrials.gov Identifier: NCT00157157 - Active, not recruiting
  Hemophilia A
  
• Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
  ClinicalTrials.gov Identifier: NCT00284193 - Active, not recruiting
  Hemophilia A
  
• Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
  ClinicalTrials.gov Identifier: NCT00289536 - Active, not recruiting
  Hemophilia A
  
• Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
  ClinicalTrials.gov Identifier: NCT00243659 - Recruiting
  Hemophilia A
  
• Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)
  ClinicalTrials.gov Identifier: NCT00340548 - Active, not recruiting
  Hemophilia
  
• Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) with Advate (FLrFVIII) in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00141843 - Active, not recruiting
  Hemophilia A
  
• Musculoskeletal Function in Hemophilia
  ClinicalTrials.gov Identifier: NCT00324493 - Active, not recruiting
  Hemophilia
  
• Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
  ClinicalTrials.gov Identifier: NCT00167973 - Recruiting
  Hemophilia B
  
• Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
  ClinicalTrials.gov Identifier: NCT00178607 - Recruiting
  Hemophilia A
  
• Gene Transfer for Subjects With Hemophilia B Factor IX Deficiency
  ClinicalTrials.gov Identifier: NCT00515710 - Recruiting
  Hemophilia B
  
• Study Comparing On-Demand Treatment With Two Prophylaxis Regimens of BeneFIX in Patients With Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00364182 - Recruiting
  Hemophilia B
  
• Efficacy of NovoSeven in Bleeding Prophylaxis in Hemophilia
  ClinicalTrials.gov Identifier: NCT00108758 - Completed
  Hemophilia A; Hemophilia B
  
• Rituximab to Treat Severe Hemophilia A
  ClinicalTrials.gov Identifier: NCT00331006 - Recruiting
  Hemophilia A
  
• Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
  ClinicalTrials.gov Identifier: NCT00243386 - Recruiting
  Hemophilia A
  
• A Prospective, Randomized, Cross-Over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors
  ClinicalTrials.gov Identifier: NCT00221195 - Recruiting
  Hemophilia A With Inhibitors
  
• Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
  ClinicalTrials.gov Identifier: NCT00323856 - Recruiting
  Severe Hemophilia A
  
• Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
  ClinicalTrials.gov Identifier: NCT00357656 - Recruiting
  Hemophilia A
  
• Hemophilia Inhibitor Genetics Study (HIGS)
  ClinicalTrials.gov Identifier: NCT00166387 - Recruiting
  Hemophilia A With Inhibitor
  
• Severe Hemophilia B Study
  ClinicalTrials.gov Identifier: NCT00037557 - Completed
  Hemophilia B
  
• Kid Cards: Teaching Kids About Medicines
  ClinicalTrials.gov Identifier: NCT00127543 - Active, not recruiting
  Hemophilia; Sickle Cell Disease; Neoplasm; Blood Coagulation Disorders
  
• ReFacto® in Subjects with Hemophilia A Undergoing Major Surgery
  ClinicalTrials.gov Identifier: NCT00092976 - Completed
  Hemophilia A
  
• Trial of NovoSeven in Hemophilia - Joint Bleeds
  ClinicalTrials.gov Identifier: NCT00108797 - Completed
  Hemophilia
  
• Evaluation of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Previously Treated Patients with Moderate to Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00093210 - Completed
  Hemophilia B
  
• Hemophilia A Study
  ClinicalTrials.gov Identifier: NCT00038909 - Completed
  Hemophilia A
  
• Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients with Hemophilia
  ClinicalTrials.gov Identifier: NCT00000705 - Completed
  HIV Infections; Hemophilia A
  
• The Second Multicenter Hemophilia Cohort Study
  ClinicalTrials.gov Identifier: NCT00341705 - Active, not recruiting
  Liver Decompensation; Hepatocellular Carcinoma; Non-Hodgking Lymphoma
  
• Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males with Hemophilia
  ClinicalTrials.gov Identifier: NCT00002386 - Completed
  HIV Infections; Hemophilia A
  
• Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00157105 - Completed
  Hemophilia A
  
• Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00168051 - Completed
  Hemophilia A
  
• Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
  ClinicalTrials.gov Identifier: NCT00581126 - Completed
  Hemophilia B
  
• Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
  ClinicalTrials.gov Identifier: NCT00581438 - Completed
  Hemophilia A; Hemophilia B
  
• Study Evaluating Inhibitor Specificity in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00151385 - Terminated
  Hemophilia A
  
• Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Patients With Acquired Hemophilia A
  ClinicalTrials.gov Identifier: NCT00306670 - Not yet recruiting
  Acquired Hemophilia A Pts Who Have Developed Anti-Factor VIII Antibodies.
  
• Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients with Hemophilia A
  ClinicalTrials.gov Identifier: NCT00157040 - Completed
  Hemophilia A
  
• Epidemiology and Immunology of Hemophilia A Inhibitors
  ClinicalTrials.gov Identifier: NCT00005518 - Completed
  Blood Disease; Hemophilia A
  
• The Effects of AZT and Ibuprofen on HIV-Infected Patients with Hemophilia
  ClinicalTrials.gov Identifier: NCT00002276 - Completed
  HIV Infections; Hemophilia A
  
• Study Evaluating Refacto for Pharmacovigilance
  ClinicalTrials.gov Identifier: NCT00195442 - Recruiting
  Hemophilia A
  
• Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901
  ClinicalTrials.gov Identifier: NCT00157053 - Completed
  Hemophilia A
  
• International Immune Tolerance Study
  ClinicalTrials.gov Identifier: NCT00212472 - Recruiting
  Hemophilia A With Inhibitors
  
• Genetic Susceptibility to Factor VIII Inhibitors
  ClinicalTrials.gov Identifier: NCT00344435 - Recruiting
  Hemophilia
  
• Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII
  ClinicalTrials.gov Identifier: NCT00245245 - Completed
  Hemophilia A
  
• Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
  ClinicalTrials.gov Identifier: NCT00189982 - Completed
  Hemophilia A
  
• A Post-Marketing Surveillance (PMS) Study of Safety and Effectiveness in Patients With BeneFIX Treatment
  ClinicalTrials.gov Identifier: NCT00484185 - Recruiting
  Hemophilia B
  
• Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients
  ClinicalTrials.gov Identifier: NCT00162019 - Completed
  Hemophilia A
  
• Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK of B-Domain Deleted Recombinant FVIII
  ClinicalTrials.gov Identifier: NCT00543439 - Recruiting
  Hemophilia A
  
• Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B
  ClinicalTrials.gov Identifier: NCT00195221 - Completed
  Hemophilia B; Allergic Reactions
  
• Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
  ClinicalTrials.gov Identifier: NCT00139828 - Completed
  Hemophilia B
  
• Treatment of Hepatitis C in Hemophilic Patients with HIV
  ClinicalTrials.gov Identifier: NCT00055341 - Completed
  HIV Infections; Hepatitis C; Hemophilia
  
• Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00076557 - Terminated
  Hemophilia B
  
• The Influence of "Karate" on Bleeding in Hemophilic Patients.
  ClinicalTrials.gov Identifier: NCT00281333 - Not yet recruiting
  Hemophilia A
  
• Hepatitis C in Clinically Discordant Hemophilic Siblings
  ClinicalTrials.gov Identifier: NCT00007371 - Completed
  Blood Disease; Hemophilia A; Hepatitis, Viral, Human
  
• Cooperative Study of Factor VIII Inhibitors
  ClinicalTrials.gov Identifier: NCT00000582 - Completed
  Blood Coagulation Disorders; Hematologic Diseases; Hemophilia A; Hemorrhagic Disorders
  
• Hepatitis Delta Infections in Hemophiliacs
  ClinicalTrials.gov Identifier: NCT00005305 - Completed
  Blood Disease; Hepatitis, Viral, Human; Liver Diseases; Hemophilia A
  
• Joint Outcome Study
  ClinicalTrials.gov Identifier: NCT00207597 - Completed
  Hemophilia A
  
• ADVATE Post Authorization Safety Surveillance
  ClinicalTrials.gov Identifier: NCT00214734 - Completed
  Hemophilia A
  
• The FEIBA NovoSeven Comparative Study
  ClinicalTrials.gov Identifier: NCT00166309 - Completed
  Severe Hemophilia A With an Inhibitor
  
• The Malmö International Brother Study (MIBS)
  ClinicalTrials.gov Identifier: NCT00231751 - Completed
  Hemophilia A With Inhibitors
  
• Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation
  ClinicalTrials.gov Identifier: NCT00375323 - Completed
  Hemophilia A
  
• Delta Hepatitis and Liver Disease in Hemophiliacs
  ClinicalTrials.gov Identifier: NCT00005304 - Completed
  Blood Disease; Hepatitis, Viral, Human; Hemophilia A; Liver Diseases
  
• Prospective Study of HIV Infection in Hemophiliacs
  ClinicalTrials.gov Identifier: NCT00005309 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections; Blood Disease; Hemophilia A; Hepatitis, Viral, Human; Blood Transfusion; ...
  
• Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
  ClinicalTrials.gov Identifier: NCT00004801 - Completed
  Hemophilia B; Factor IX Deficiency
  
• Clot Formation and Clot Stability in Patients With Severe Haemophilia A
  ClinicalTrials.gov Identifier: NCT00279578 - Completed
  Hemophilia A
  
• A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia
  ClinicalTrials.gov Identifier: NCT00001104 - Completed
  HIV Infections